Abiopharma

New Form 4 - Nuvalent, Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091016 Size: 21 KB

New Form 4 - Regulus Therapeutics Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091015 Size: 33 KB

New Form 4 - Regulus Therapeutics Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091008 Size: 42 KB

New Form 144 - Entrada Therapeutics, Inc. Filed: 2025-06-27 AccNo: 0000803012-25-000012 Size: 4 KB

New Form 4 - Regulus Therapeutics Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091006 Size: 25 KB

New Form 4 - Regulus Therapeutics Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091003 Size: 43 KB

Stranger Things: Every Major Update Heading Into the Epic Final Season

New Form 4 - Acadia Healthcare Company, Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091002 Size: 4 KB

New Form 4 - Acadia Healthcare Company, Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091000 Size: 4 KB

New Form 4 - Acadia Healthcare Company, Inc. Filed: 2025-06-27 AccNo: 0000950170-25-091001 Size: 4 KB

New Form 4 - Roivant Sciences Ltd. Filed: 2025-06-27 AccNo: 0000950170-25-090997 Size: 18 KB

New Form 4 - Roivant Sciences Ltd. Filed: 2025-06-27 AccNo: 0000950170-25-090993 Size: 15 KB

New Form 4 - Roivant Sciences Ltd. Filed: 2025-06-27 AccNo: 0000950170-25-090994 Size: 12 KB

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-06-27 AccNo: 0001437749-25-021445 Size: 164 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 4 - Regulus Therapeutics Inc. Filed: 2025-06-27 AccNo: 0000950170-25-090992 Size: 20 KB